Biotech Values

[drbio45]

Good decision, IMO. PFE’s share price not only values the pipeline at close to zero, but also discounts the continuing EPS gain from post-merger cost-cutting. All told, the Wyeth acquisition will boost PFE’s profitability by more than a Lipitor-sized drug would be able to do



What is pfizer going to earn in 2010, 2011, and 2012.

How do they make of for 12 billion in lipitor sales with a gross margin of 85 to 90 percent.